Intrahepatic cholestasis and eclampsia: A case report

Hypertension in Pregnancy

Volumn 26, Issue 4, 2007, Pages 363-369

  Atabey, Seval ^a   Duvan, Candan Iltemir ^a,b   Eren, Ünal ^a   Turhan, Nilgün Öztürk ^a  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b NONE   (Turkey)

Author keywords

Eclampsia; Intrahepatic cholestasis; Pregnancy

Indexed keywords

CETIRIZINE; GLYCERYL TRINITRATE; MAGNESIUM SULFATE; METHYLDOPA; URSODEOXYCHOLIC ACID;

ADD ON THERAPY; ADULT; ARTERIAL PRESSURE; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; DRUG TREATMENT FAILURE; ECLAMPSIA; FEMALE; HOSPITAL DISCHARGE; HUMAN; INTRAHEPATIC CHOLESTASIS; LABORATORY TEST; MATERNAL HYPERTENSION; OUTCOME ASSESSMENT; PREGNANCY; TREATMENT PLANNING; TREATMENT RESPONSE;

ADULT; CESAREAN SECTION; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS, INTRAHEPATIC; DISSEMINATED INTRAVASCULAR COAGULATION; ECLAMPSIA; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; URSODEOXYCHOLIC ACID;

EID: 36849088010     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950701581159     Document Type: Article

References (33)

1. Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer J, Germain AM. Intrahepatic cholestasis of pregnancy: A retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994; 170: 890-895.
2. Germain AM, Carvajal JA, Glasinovic JC, et al. Intrahepatic cholestasis of pregnancy: an intriguing pregnancy-specific disorder. Soc Gynecol Invest 2002; 9(1):10-14.
3. Elizabeth A. Fagan MS. Intrahepatic cholestasis of pregnancy. Clin Liver Dis 1999; 3:(3):603-632.
4. Bacq Y, Sapey T, Brechot MC, Pierre F, Fignon A, Dubois F. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 1997; 26(2):358-364.
5. Fagan EA. Diseases of the liver, biliary system and pancreas. In Creasy RK, Resnik R, eds: Maternal-fetal medicine, 4th ed. Philadelphia: WB Saunders, 1999: 1054.
6. Fagan EA. Intrahepatic cholestasis of pregnancy. BMJ. 1994; 309:1243-1244.
7. Knox TA, Olans LB. Liver disease in pregnancy. N Engl J Med 1996; 335:569.
8. Rolfes DB, Ishak KG. Acute fatty liver of pregnancy: A clinicopathological study of 35 cases. Hepatology 1985; 5:1149.
9. Gonzales MC, Reyes H, Arrese M, et al. Intrahepatic cholestasis of pregnancy in twin pregnancies. J Hepatol 1989; 9:84.
10. Serrano MA, Brites D, Larena MG, et al. Beneficial effect of UDCA on alteration induced by cholestasis of pregnancy in bile acid transport across the human placenta. J Hepatol 1998; 28:29.
11. Glantz A, Marschall HU, Matson LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004; 40(2):467-474.
12. Tyni T, Pihko H. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Acta Paediatr 1999:88(3) 237-245.
13. Goulis DG, Walker IA, de Swiet M, et al. Preeclampsia with abnormal liver function tests is associated with cholestasis in a subgroup of cases. Hypertens Pregnancy 2004; 23(1):19-27.
14. Leevy CB, Koneru B, Klein KM. Recurrent familial prolonged intrahepatic cholestasis of pregnancy associated with chronic liver disease. Gastroenterology 1998; 113:966-967.
15. Meng LJ, Reyes H, Axelson M, et al. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy. Hepatology 1997; 26:1573-1579.
16. Meng L, Reyes H, Palma J, et al. Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. J Hepatol 1997; 27:1029-1040.
17. Palmer DG, Eads J. Intrahepatic cholestasis of pregnancy: A critical review. J Perinat Neonatal Nurs 2000; 14(1):39-51.
18. Bull LN, Carlton VE, Stricker NL, Baharloo S, DeYoung JA, Freimer NB, Magid MS, Kahn E, Markowitz J, DiCarlo FJ, McLoughlin L, Boyle JT, Dahms BB, Faught PR, Fitzgerald JF, Piccoli DA, Witzleben CL, O'Connell NC, Setchell KD, Agostini RM Jr, Kocoshis SA, Reyes J, Knisely AS. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 1997; 26(1):155-164.
19. Bull LN, van Eijk MJ, Pawlikowska L, DeYoung JA, Juijn JA, Liao M, Klomp LW, Lomri N, Berger R, Scharschmidt BF, Knisely AS, Houwen RH, Freimer NB. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998; 18(3):219-224.
20. Mullenbach R, Bennett A, Tetlow N, Patel N, Hamilton G, Cheng F, Chambers J, Howard R, Taylor-Robinson SD, Williamson C. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut 2005; 54(6):829-834.
21. Painter JN, Savander M, Ropponen A, et al. Sequence variation in the ATP8B1 gene intrahepatic cholestasis of pregnancy. Eur J Hum Genet 2005; 13(4):435-439.
22. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V, Tanner MS, Kagalwalla AF, Nemeth A, Pawlowska J, Baker A, Mieli-Vergani G, Freimer NB, Gardiner RM, Thompson RJ. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998; 20(3):233-238.
23. Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, Meier PJ. Drug and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 2000; 118(2):422-430.
24. Eloranta ML, Hakli T, Hiltunen M, et al. Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy. Scand J Gastroenterol 2003; 38(6):648-652.
25. Jacquemin E, Cresteil D, Manouvrier S, et al. Heterozygous non-sense mutation of MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353:210-211.
26. Dixon PH, Weerasekera N, Linton KJ, Donaldson O, Chambers J, Egginton E, Weaver J, Nelson-Piercy C, de Swiet M, Warnes G, Elias E, Higgins CF, Johnston DG, McCarthy MI, Williamson C. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet. 2000; 9(8):1209-1217.
27. Floreani A, Carderi I, Paternoster D, et al. Intrahepatic cholestasis of pregnancy: there novel MDR3 gene mutuations. Aliment Pharmacol Ther 2006; 23(11):1649-1653.
28. Wasmuth HE, Glantz A, Keppeler H, et al. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter gene ABCB4. Gut 2006: (Epub ahead of print).
29. Pauli-Magnus C, Lang T, Meier Y, Marin TZ, Jung D, et al. Sequence analysis of bile salt pump(ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics, 2004; 14(2):91-102.
30. Savander M, Ropponen A, Avela K, et al. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut 2003; 52(7):1025-1029.
31. Lammert F, Marschall HU, Matern S. Intrahepatic Cholestasis of Pregnancy. Curr Treat Options Gastroenterol 2003; 6(2):123-132.
32. Lengeyel G, Feher R, Gardo S, et al. Ursodeoxycholic acid treatment in intrahepatic cholestasis of pregnancy. A case report. Orv Hetil 2002; 143(52):2885-2888.
33. Glantz A, Marschall HU, Lammert F, et al. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005; 42(6):1399-1405.